Biostatistics

Papers
(The TQCC of Biostatistics is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Estimation of optimal treatment regimes with electronic medical record data using the residual life value estimator57
High-dimensional test for one-sided hypotheses30
Stochastic gradient descent estimation of generalized matrix factorization models with application to single-cell RNA sequencing data18
Inference after latent variable estimation for single-cell RNA sequencing data18
Multi-study R -learner for estimating heterogeneous treatment effects across studies using statistical machine learning15
Dynamic case-control sampling for rapid estimation of vaccine effectiveness against an emerging infectious disease variant13
Signal detection statistics of adverse drug events in hierarchical structure for matched case–control data12
A joint Bayesian hierarchical model for estimating SARS-CoV-2 genomic and subgenomic RNA viral dynamics and seroconversion12
Time-to-event surrogate endpoint validation using mediation analysis and meta-analytic data11
DifferentialRegulation : a Bayesian hierarchical approach to identify differentially regulated genes11
Differences in set-based tests for sparse alternatives when testing sets of outcomes compared to sets of explanatory factors in genetic association studies11
Practical causal mediation analysis: extending nonparametric estimators to accommodate multiple mediators and multiple intermediate confounders10
A scalable approach for continuous time Markov models with covariates10
An intersectional framework for counterfactual fairness in risk prediction8
Multivariate spatiotemporal functional principal component analysis for modeling hospitalization and mortality rates in the dialysis population8
DP2LM: leveraging deep learning approach for estimation and hypothesis testing on mediation effects with high-dimensional mediators and complex confounders8
Analyzing microbial evolution through gene and genome phylogenies7
Determining vaccine responders in the presence of baseline immunity using single-cell assays and paired control samples7
Semi-supervised calibration of inferred outcomes for estimating average treatment effects with validated outcomes7
Evaluating dynamic and predictive discrimination for recurrent event models: use of a time-dependent C-index7
Addressing the mean–variance relationship in spatially resolved transcriptomics data with spoon6
A Bayesian approach to estimating COVID-19 incidence and infection fatality rates6
Covariate-guided Bayesian mixture of spline experts for the analysis of multivariate high-density longitudinal data6
Bayesian joint modeling of multivariate longitudinal and survival outcomes using Gaussian copulas6
Multiple exposure distributed lag models with variable selection5
Correction to: A transformation perspective on marginal and conditional models5
A scalable and unbiased discordance metric with H +5
Estimating the heritability of longitudinal rate-of-change: genetic insights into PSA velocity in prostate cancer-free individuals5
A Bayesian nonparametric approach to correct for underreporting in count data4
SAM-HC: a Bayesian nonparametric construction of hybrid control for randomized clinical trials using external data4
Improved efficiency for cross-arm comparisons via platform designs4
A Bayesian approach for investigating the pharmacogenetics of combination antiretroviral therapy in people with HIV4
Identifying predictors of resilience to stressors in single-arm studies of pre–post change4
Exponential family measurement error models for single-cell CRISPR screens4
Functional support vector machine4
0.063381195068359